Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Total Liabilities came in at $1.1 billion in Q1 2026, up 27.3% year-on-year from $891.0 million in Q1 2025, and little changed on a QoQ basis from $1.1 billion in Q4 2025.
Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Total Liabilities data on file, last reported at $1.1 billion in Q1 2026.
- On a quarterly basis, Total Liabilities rose 27.3% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 27.3% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 27.49% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.1 billion, roughly flat from $1.1 billion in the prior quarter.
- Over the last five years, Total Liabilities for LNTH reached as high as $1.2 billion in Q3 2025 and fell as low as $417.3 million in Q1 2022.
- Historically, Total Liabilities has averaged $845.5 million across 5 years, with a median of $885.8 million in 2024.
- Across the five-year window, Total Liabilities jumped 118.89% in 2022 and declined 4.44% in 2023, its largest moves.
- Year by year, Total Liabilities stood at $874.1 million in 2022, then retreated by 4.44% to $835.3 million in 2023, then gained by 6.83% to $892.3 million in 2024, then increased by 27.49% to $1.1 billion in 2025, then declined by 0.29% to $1.1 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 1.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 949.29 Mn |
| Mar 31, 2025 | 891.03 Mn |
| Dec 31, 2024 | 892.33 Mn |
| Sep 30, 2024 | 869.92 Mn |
| Jun 30, 2024 | 913.15 Mn |
| Mar 31, 2024 | 885.79 Mn |
| Dec 31, 2023 | 835.26 Mn |
| Sep 30, 2023 | 822.85 Mn |
| Jun 30, 2023 | 785.08 Mn |
| Mar 31, 2023 | 903.77 Mn |
| Dec 31, 2022 | 874.11 Mn |
| Sep 30, 2022 | 457.89 Mn |
| Jun 30, 2022 | 446.49 Mn |
| Mar 31, 2022 | 417.32 Mn |
| Dec 31, 2021 | 399.35 Mn |
| Sep 30, 2021 | 348.47 Mn |
| Jun 30, 2021 | 349.66 Mn |